# The National Health Service (General Medical Services) (Scotland) Amendment Regulations 2003

S.S.I. 2003/11 · made 8 January 2003

These Regulations amend the National Health Service (General Medical Services) (Scotland) Regulations 1995 (“the principal Regulations”) which regulate the terms on which doctors provide general medical services under the National Health Service (Scotland) Act 1978 (“the 1978 Act”).

Made under: National Health Service (Scotland) Act 1978 (Section 19, Section 105, Section 108)

## Introductory text

NATIONAL HEALTH SERVICE
Made 8th January 2003
Laid before the Scottish Parliament 10th January 2003
Coming into force 1st February 2003
The Scottish Ministers, in exercise of the powers conferred by sections 19, 105(7) and 108(1) of the National Health Service (Scotland) Act 1978, and of all other powers enabling them in that behalf, hereby make the following Regulations:

## 1 Citation, commencement and interpretation

(1) These Regulations may be cited as the National Health Service (General Medical Services) (Scotland) Amendment Regulations 2003 and shall come into force on 1st February 2003.
(2) In these Regulations, “the principal Regulations” means the National Health Service (General Medical Services) (Scotland) Regulations 1995.

## 2 Amendment of Schedule 10 to the principal Regulations

In Schedule 10 to the principal Regulations (drugs and other substances not to be supplied by general medical practitioners or prescribed for supply under pharmaceutical services) the following entries shall be deleted:–
Fabrol Granules
Fluimucil Granules
Methylcisteine Tablets 100 mg
Mucodyne Capsules
Mucodyne Forte Syrup
Mucodyne Forte Tablets
Mucodyne Paediatric Syrup
Mucodyne Syrup
Visclair Tablets

## 3 Amendment of Schedule 11 to the principal Regulations

In Schedule 11 to the principal Regulations (drugs to be supplied by general medical practitioners or prescribed for supply under pharmaceutical services only in certain circumstances)–
(a) the following entries shall be deleted:–
“Acetylcysteine Granules” in column 1 and the entries in columns 2 and 3 which relate to that entry;
“Carbocisteine” in column 1 and the entries in columns 2 and 3 which relate to that entry; and
(b) after the entry “Moxisylyte Hydrochloride (Erecnos)” in each of columns 1 and 2 there is inserted “Tadalafil (Cialis)”.

## Signature

MALCOLM CHISHOLM
A member of the Scottish Executive
St Andrew’s House, Edinburgh
8th January 2003

## Explanatory note

(This note is not part of the Regulations)
These Regulations amend the National Health Service (General Medical Services) (Scotland) Regulations 1995 (“the principal Regulations”) which regulate the terms on which doctors provide general medical services under the National Health Service (Scotland) Act 1978 (“the 1978 Act”).
Regulation 2 removes 9 products from Schedule 10 to the principal Regulations, which identifies those drugs and other substances which are not to be supplied by general medical practitioners or prescribed for supply in the course of pharmaceutical services under the 1978 Act.
Regulation 3(a) removes 2 products from, and regulation 3(b) adds 1 product to, Schedule 11 to the principal Regulations, which identifies those drugs which may be supplied by general medical practitioners or prescribed for supply under pharmaceutical services only in certain circumstances.

---
Source: https://www.legislation.gov.uk/ssi/2003/11 (the official version)
Page: https://openlegislation.uk/national-health-service-general-medical-services-scotland-amendment-regulations-2003
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.